Human leukocyte antigen (HLA)-B27-positive subjects are uncommon in their ability to control
infection with human immunodeficiency virus type 1 (HIV-1). However, late viral escape …

Human immunodeficiency virus type 1 (HIV-1) elite controllers (EC) maintain viremia below
the limit of commercial assay detection (<50 RNA copies/ml) in the absence of antiviral …

Murine models indicate that interleukin-10 (IL-10) can suppress viral clearance, and
interventional blockade of IL-10 activity has been proposed to enhance immunity in chronic viral …

Certain histocompatibility leukocyte antigen (HLA) alleles are associated with improved clinical
outcomes for individuals infected with human immunodeficiency virus type 1 (HIV-1), but …

The human leukocyte antigens HLA-B*27 and HLA-B*57 are associated with protection
against progression of disease that results from infection with human immunodeficiency virus …

… Brockman, Elizabeth E. Mc … Travis J Taylor, Mark A. Brockman, Elizabeth E. McNamee,
and David M. Knipe …

Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …

Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …

Background Despite the extensive genetic diversity of HIV-1, viral evolution in response to
immune selective pressures follows broadly predictable mutational patterns. Sites and …

Defining the T helper functions impaired by programmed death–1 (PD-1) is crucial for
understanding its role in defective HIV control and determining the therapeutic potential of …